HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Françoise Reuter Selected Research

Natalizumab (Tysabri)

11/2017Improvement of quality of life and its relationship with neuropsychiatric outcomes in patients with multiple sclerosis starting treatment with natalizumab: A 3-year follow-up multicentric study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Françoise Reuter Research Topics

Disease

3Multiple Sclerosis
11/2017 - 05/2012
1Fatigue
11/2017

Drug/Important Bio-Agent (IBA)

1Natalizumab (Tysabri)FDA Link
11/2017
1SodiumIBA
02/2014
1Immunoglobulin M (IgM)IBA
05/2012

Therapy/Procedure

1Therapeutics
11/2017